120 related articles for article (PubMed ID: 37642311)
21. Cell Line-Dependent Variability of Coordinate Expression of p75NTR and CRABP1 and Modulation of Effects of Fenretinide on Neuroblastoma Cells.
Yang YP; Wang S; Li X; Schor NF
Oxid Med Cell Longev; 2016; 2016():7568287. PubMed ID: 26843908
[TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
[TBL] [Abstract][Full Text] [Related]
23. LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels.
Zhao H; Zhu X; Luo Y; Liu S; Wu W; Zhang L; Zhu J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786631
[TBL] [Abstract][Full Text] [Related]
24. Downregulated long noncoding RNA LINC00313 inhibits the epithelial-mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4.
Zhao X; Hu X
J Cell Physiol; 2019 Nov; 234(11):20992-21004. PubMed ID: 31093972
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation.
Meng X; Kong DH; Li N; Zong ZH; Liu BQ; Du ZX; Guan Y; Cao L; Wang HQ
Cell Death Dis; 2014 Feb; 5(2):e1092. PubMed ID: 24577090
[TBL] [Abstract][Full Text] [Related]
26. All-trans retinoic acid attenuates isoproterenol-induced cardiac dysfunction through Crabp1 to dampen CaMKII activation.
Park SW; Nhieu J; Lin YW; Wei LN
Eur J Pharmacol; 2019 Sep; 858():172485. PubMed ID: 31238067
[TBL] [Abstract][Full Text] [Related]
27. SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.
Zhou Q; Chen J; Feng J; Xu Y; Zheng W; Wang J
Mol Cell Biochem; 2017 Nov; 435(1-2):87-95. PubMed ID: 28551845
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
29. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
Lim WC; Kim H; Ko H
J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
[TBL] [Abstract][Full Text] [Related]
30. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
Min WP; Wei XF
Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
[TBL] [Abstract][Full Text] [Related]
31. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).
Zanetti A; Affatato R; Centritto F; Fratelli M; Kurosaki M; Barzago MM; Bolis M; Terao M; Garattini E; Paroni G
J Biol Chem; 2015 Jul; 290(29):17690-17709. PubMed ID: 26018078
[TBL] [Abstract][Full Text] [Related]
32. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
[TBL] [Abstract][Full Text] [Related]
33. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
[TBL] [Abstract][Full Text] [Related]
34. TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.
Chen XH; Liu ZC; Zhang G; Wei W; Wang XX; Wang H; Ke HP; Zhang F; Wang HS; Cai SH; Du J
Mol Immunol; 2015 May; 65(1):34-42. PubMed ID: 25618241
[TBL] [Abstract][Full Text] [Related]
35. All-
Nagpal I; Wei LN
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344789
[TBL] [Abstract][Full Text] [Related]
36. Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
Chin LH; Hsu SP; Zhong WB; Liang YC
PLoS One; 2015; 10(3):e0118674. PubMed ID: 25742642
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
[TBL] [Abstract][Full Text] [Related]
38. CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases.
Nhieu J; Lin YL; Wei LN
Nutrients; 2022 Apr; 14(7):. PubMed ID: 35406141
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway.
Lefebvre B; Brand C; Flajollet S; Lefebvre P
Mol Endocrinol; 2006 Sep; 20(9):2109-21. PubMed ID: 16613989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]